Chiba Suguru, Abe Masami, Nakamura Kentaro, Uehara Hiroki
Department of Cardiology, Urasoe General Hospital, 4-16-1 Iso Urasoe, Okinawa 9012132, Japan.
Eur Heart J Case Rep. 2023 Aug 7;7(8):ytad379. doi: 10.1093/ehjcr/ytad379. eCollection 2023 Aug.
Transcoronary ethanol ablation is effective in treating ventricular tachycardia (VT) in the deep myocardium. The selection of the target coronary artery plays an important role in the success of transcoronary ethanol ablation. Transcoronary mapping, using a guidewire, may be effective for identifying the target coronary artery.
A 72-year-old man, who had undergone thrombolytic therapy for acute myocardial infarction 40 years ago, was admitted to the emergency department with a chief complaint of syncope. Five years ago, a cardiac resynchronization therapy defibrillator was implanted for a left bundle branch block (QRS duration 153 ms), with New York Heart Association Class Ⅲ and a left ventricular ejection fraction of 30%.Due to VT, he experienced a critical deterioration in his vital parameters, leading to shock. The first VT ablation was performed on the 3rd day of hospitalization. Activation mapping showed that the earliest activation site was located in the mid-anterior septum of the left ventricle. Mapping from the endocardial surface showed no mid-diastolic potential around the VT. Radiofrequency catheter ablation therapy was performed at the targeted site, resulting in transient termination of VT. However, the VT showed recurrence the next day. A transcoronary ethanol ablation was performed on the 10th day of hospitalization. A 0.014 inch guidewire and microcatheter were advanced into the target coronary septal branch, and the myocardial septum was mapped. The guidewire-assisted transcoronary mapping showed a potential 43 ms ahead of QRS onset during VT. The coronary septal artery branch was considered the target artery, and 0.5 mL of ethanol was injected. No further VT was observed for 12 months after the transcoronary ethanol ablation.
Transcoronary ethanol ablation is considered in cases where a deep intramural substrate is suspected or when early activation at the interventricular septum is identified. Guidewire-assisted transcoronary mapping allows mapping of VT with deep intramural substrates and may be useful in selecting target coronary arteries while performing transcoronary ethanol ablation.
经冠状动脉乙醇消融术在治疗深部心肌的室性心动过速(VT)方面有效。目标冠状动脉的选择在经冠状动脉乙醇消融术的成功中起着重要作用。使用导丝进行冠状动脉标测可能有助于识别目标冠状动脉。
一名72岁男性,40年前因急性心肌梗死接受过溶栓治疗,因晕厥为主诉入住急诊科。5年前,因左束支传导阻滞(QRS时限153 ms)植入心脏再同步化治疗除颤器,纽约心脏协会心功能Ⅲ级,左心室射血分数30%。因室性心动过速,其生命体征急剧恶化,导致休克。住院第3天进行了首次室性心动过速消融。激动标测显示最早激动部位位于左心室前间隔中部。心内膜面标测未显示室性心动过速周围的舒张中期电位。在靶点进行了射频导管消融治疗,导致室性心动过速短暂终止。然而,室性心动过速次日复发。住院第10天进行了经冠状动脉乙醇消融。将一根0.014英寸的导丝和微导管推进到目标冠状动脉间隔支,对心肌间隔进行标测。导丝辅助冠状动脉标测显示室性心动过速发作时比QRS波起始提前43 ms的电位。冠状动脉间隔动脉分支被认为是目标动脉,注入了0.5 mL乙醇。经冠状动脉乙醇消融术后12个月未再观察到室性心动过速。
在怀疑存在深部心肌内基质或确定室间隔早期激动时,考虑行经冠状动脉乙醇消融术。导丝辅助冠状动脉标测可对深部心肌内基质的室性心动过速进行标测,在进行经冠状动脉乙醇消融术时可能有助于选择目标冠状动脉。